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Calcium (Ca2þ) is known to be a key messenger in cardiac
excitation-contraction coupling. Alterations in excitation-
contraction coupling reportedly play a crucial role in the
pathogenesis of heart failure and lethal arrhythmias, such as
catecholaminergic polymorphic ventricular tachycardia
(CPVT) (1,2). The common pathophysiologic phenomenon
occurring in the 2 above-mentioned heart diseases is termed
as a “diastolic Ca2þ leak,” which involves an aberrant release
of Ca2þ during diastole via the cardiac ryanodine receptor
(RyR2) (3).See page 1569In heart failure, a diastolic Ca2þ leak through RyR2 re-
sults in a decrease in the sarcoplasmic reticulum (SR) Ca2þ
content, along with a decrease in Ca2þ uptake by SR Ca2þ
adenosine triphosphatase 2a (1). However, in cases of
CPVT, wherein >150 mutation sites in RyR2 have been
identiﬁed, a Ca2þ leak occurs on beta-adrenergic stimulation
without a decrease in SR Ca2þ content, because SR Ca2þ
adenosine triphosphatase 2a activity is normally restored in
such cases. In cases of either heart failure or CPVT,
the Ca2þ leak commonly provides a substrate for delayed
afterdepolarization, which leads to life-threatening ar-
rhythmia (2,3). Four hypotheses have been proposed to
explain the mechanism underlying the Ca2þ leak observed
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contents of this paper to disclose.involves post-translational modiﬁcations such as oxidation,
S-nitrosylation, and phosphorylation of RyR2 (1–4)
(Fig. 1). RyR2 function is modulated by protein kinase A
(PKA)–mediated phosphorylation and the subsequent
dissociation of FK506 binding protein 12.6 (FKBP12.6)
from RyR2 (4). The depletion of FKBP12.6, caused by the
hyperphosphorylation of RyR2 by PKA on beta-adrenergic
stimulation, is thought to destabilize RyR2; however, this
hypothesis remains highly controversial (5). The second
mechanism involves direct activation of Ca2þ/calmodulin-
dependent kinase II (CaMKII) by excessive catecholamine
(5). Phosphorylation of RyR2 by CaMKII is another
candidate for modulation of RyR2 function, which can
subsequently cause a Ca2þ leak (5). The third mechanism
involves defective interdomain interaction between the
N-terminal (amino acids 1 to 600) and central domain
(amino acids 2,000 to 2,500) of RyR2 (3). In a normal state,
the N-terminal and central domains interact with each other
to act as a regulatory switch for channel-gating activity, with
a tight zipping of the interacting domains serving to stabilize
RyR2. The weakness of the interdomain interaction results
in an increasing tendency toward unzipping, leading to
leakiness of RyR2 in the diseased state. In the canine
pacing-induced heart failure model, both K201, which binds
to the central domain of RyR2 (6), and dantrolene, which
binds to the N-terminal domain (7), prevented the pro-
gression of heart failure. The fourth mechanism involves a
store overload-induced Ca2þ release (8). The threshold of
SR Ca2þ load for channel activation, regulated by luminal
[Ca2þ], but not by cytosolic [Ca2þ] in the SR, is markedly
reduced in the mutated RyR2.
Several knock-in (KI) mouse models with CPVT-linked
mutations of RyR2dsuch as R4496C (9) and R2474S
(10)dhave been established, and these KI mouse models
have all clearly indicated that only a single point mutation
in RyR2 causes lethal arrhythmia, although the severity
(frequency of ventricular tachycardia [VT] on beta-
adrenergic stimulation) differs according to the mutation
site in RyR2. Studies of such KI mouse models provided
several important points on the pathological mechanisms
of CPVT, such as: 1) bidirectional VT originates through
alternative spontaneous activation of either the right or
left ventricular Purkinje ﬁbers (11); and 2) overactivation
of CaMKII appears to be an essential factor for promoting
progression toward heart failure and ventricular arrhythmia
(12).
In this issue of the Journal, Sedej et al. (13) stated an
important ﬁnding using a R4496C KI mouse model
wherein a Ca2þ leakdmediated through the mutated
RyR2dpromoted pressure overload-induced myocardial
remodeling and inhibition of Ca2þ leak by the RyR2 sta-
bilizer K201, thus preventing the progression toward cardiac
hypertrophy and heart failure. The most important ﬁnding
of that study is that even a small Ca2þ leak through RyR2 is
directly linked to the pathogenesis of cardiac hypertrophy
and failure, and the speciﬁc inhibition of the Ca2þ leak
Figure 1 Schematic Diagram Showing How a Diastolic Ca2þ Leak Predisposes to HF and Lethal Arrhythmia
Four hypotheses have been proposed to explain a Ca2þ leak: (A) post-translational modiﬁcations such as oxidation, S-nitrosylation, and phosphorylation of cardiac ryanodine
receptor 2 (RyR2); (B) direct activation of Ca2þ/calmodulin-dependent protein kinase II (CaMKII) by excessive catecholamine via nitric oxide (NO) production; (C) defective
interdomain interaction within RyR2; and (D) store overload-induced Ca2þ release (SOICR). The Ca2þ leak may subsequently lead to lethal arrhythmia, with pathological
hypertrophy in some cases, and heart failure (HF). AngII ¼ angiotensin II; bAR ¼ beta-adrenergic receptor; [Ca2þ] ¼ free calcium concentration; DAD ¼ delayed after-
depolarization; ET ¼ endothelin; FKBP12.6 ¼ FK506 binding protein; 12.6; GPCR ¼ G protein coupled receptor; HF ¼ heart failure; NADPH ¼ nicotinamide adenine dinucleotide
phosphate; P ¼ phosphorylation; PKA ¼ protein kinase A; ROS ¼ reactive oxygen species; SERCA2a ¼ sarcoplasmic reticulum Ca2þ-adenosine triphosphatase 2a; TNFa ¼
tumor necrosis factor alpha; XO ¼ xanthine oxidase.
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failure and resulted in improved prognosis.
The ﬁnding that another RyR2 stabilizer, dantrolene,
which has been shown to ﬁx the defective interdomain
interaction (7), reduces the frequency of Ca2þ sparks in KI
cardiomyocytes strongly supports the idea that RyR2
dysfunction in KI mice with thoracic aortic constriction
(TAC) may be largely inﬂuenced by defective interdomain
interaction between the N-terminal and central domain of
RyR2. Thus, the Ca2þ leak caused by the defective inter-
domain interaction of RyR2 may have a direct effect on the
progression of cardiac hypertrophy and heart failure.
However, several concerns exist that remain to be clariﬁed.
In a R4496C KI mouse model with TAC, the phosphory-
lation level was not altered at either Ser2808 or Ser2814 in
RyR2. Moreover, in cardiomyocytes from the hearts of a
R4496C KI mouse model with TAC, the CaMKII inhibitor
KN93 had no signiﬁcant effect on Ca2þ sparks in car-
diomyocytes, suggesting that CaMKII has only a minor role
in the pathogenesis of abnormal Ca2þ handling and cardiac
hypertrophy. These ﬁndings appear to be inconsistent with
those of previous studies, which showed that: 1) phosphor-
ylation of RyR2 by CaMKIIdbut not by PKAdplays acrucial role in the Ca2þ leak and the development of heart
failure in a mouse model of TAC (14); and 2) overexpression
of CaMKIIdeltaC in R4496C KI increased the PKA- and
CaMKII-mediated phosphorylation of RyR2 with progres-
sive heart failure and ventricular arrhythmia (12).
The reasons for such discordance remain unclear. The
mechanistic relationship between PKA- and CaMKII-
mediated phosphorylation of RyR2, diastolic Ca2þ leak,
and development of cardiac hypertrophy and heart failure
remains to be clariﬁed.
With regard to the factor affecting channel gating of RyR2
in diseased hearts, a nitroso-redox imbalance has been pro-
posed to cause RyR2 oxidation, hyponitrosylation, and SR
Ca2þ leak (15). Moreover, recent reports have indicated that
that nitric oxide is produced on beta-adrenergic stimulation,
and subsequently, CaMKII is activated, resulting in a surge
of diastolic Ca2þ sparks and increased wave propensity (16).
However, the precise mechanism for Ca2þ leak and its
pathogenic role in post-translational signal transduction to-
ward cardiac hypertrophy remains uncertain.Although further
investigation is required to resolve many questions on Ca2þ
leak, stabilization of RyR2 appears to provide a new gateway
for the treatment of cardiac hypertrophy and heart failure.
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